Clinical Trials Browser

Completed × Neoplasms × HMPL-013 × Clear all

NCT06202599 2024-01-17

Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance

Bone Neoplasms, Neoplasms, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT01645215 2020-02-17

Phase I Study of Fruquintinib(HMPL-013) in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms